RETRACTED: Usefulness of Systemic Computed Tomography (CT) Scanning in the Detection of Malignant Lymphadenopathy (Retracted Article)

被引:2
作者
Ichikawa, Kunimoto
Sugimoto, Koichi [1 ]
Isobe, Yasushi
Kuwatsuru, Ryohei [2 ]
Sasaki, Makoto
Horiguchi, Itsuko [3 ]
Komatsu, Norio
机构
[1] Juntendo Univ, Dept Internal Med, Div Hematol, Sch Med,Bunkyo Ku, Tokyo 1138421, Japan
[2] Juntendo Univ, Sch Med, Dept Internal Med, Dept Radiol, Tokyo 1138421, Japan
[3] Juntendo Univ, Sch Med, Dept Publ Hlth, Tokyo 1138421, Japan
关键词
ILL CANCER-PATIENTS; LYMPH-NODE BIOPSY; PROGNOSTIC SCORE; HODGKINS-DISEASE; SERUM; SURVIVAL;
D O I
10.1097/MD.0b013e31823913f2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We developed a prediction model to distinguish between malignant and nonmalignant lymphadenopathies. We first analyzed clinical features of 222 patients with lymphadenopathy (161 malignant and 61 nonmalignant) in the derivation group. Through logistic regression analysis we identified 6 covariates that independently predict malignancy: age (X-1), abdominal lymphadenopathy (X-2), lymphadenopathy of the other sites (X-3), number of enlarged lymph node regions (X-4), absence of fever (X-5), and largest lymph node size (X-6). We determined the formula as follows: predictive score = -2.3 + x(1) + 2.8x(2) + 1.3x(3) + 1.6x(4) - 2.2x(5) + 1.8x(6). A higher score correlated with increased likelihood of malignancy. With the cutoff value of 0.4, the sensitivity and specificity of the model were 91.9% and 77.0%, respectively. The validation study using 117 cases (82 malignant and 35 nonmalignant) yielded 90.2% sensitivity and 68.6% specificity. A maximum lymph node size of less than 2.0 cm on systemic computed tomography (CT) scanning indicated a low probability of malignant lymphadenopathy. In this model, 4 of the 6 covariates were obtained by CT scanning, which strongly indicates the usefulness of initial evaluation with systemic CT scanning in the detection of malignant lymphadenopathy. (Medicine 2011;90: 396-403)
引用
收藏
页码:396 / 403
页数:8
相关论文
共 20 条
[1]   SERUM SOLUBLE INTERLEUKIN-2 RECEPTOR LEVELS ARE ASSOCIATED WITH CLINICAL-DISEASE STATUS AND HISTOPATHOLOGICAL GRADE IN NON-HODGKIN LYMPHOMA AND CHRONIC LYMPHOCYTIC-LEUKEMIA [J].
BARAK, V ;
GINZBURG, M ;
KALICKMAN, I ;
POLLIACK, A .
LEUKEMIA & LYMPHOMA, 1992, 7 (5-6) :431-438
[2]   Enigmatic Kikuchi-Fujimoto disease a comprehensive review [J].
Bosch, X ;
Guilabert, A ;
Miquel, R ;
Campo, E .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2004, 122 (01) :141-152
[3]  
Dispenzieri Angela, 2008, V142, P293
[4]  
Greene FL, 2002, LYMPHOID NEOPLASMS A, P393
[5]   Serum soluble interleukin-2 receptor measurement in patients with sarcoidosis - A clinical evaluation [J].
Grutters, JC ;
Fellrath, JM ;
Mulder, L ;
Janssen, R ;
van den Bosch, JMM ;
van Velzen-Blad, H .
CHEST, 2003, 124 (01) :186-195
[6]  
Habermann TM, 2000, MAYO CLIN PROC, V75, P723
[7]   A prognostic score for advanced Hodgkin's disease [J].
Hasenclever, D ;
Diehl, V .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (21) :1506-1514
[8]   Biological indices predictive of survival in 519 Italian terminally ill cancer patients [J].
Maltoni, M ;
Pirovano, M ;
Nanni, O ;
Marinari, M ;
Indelli, M ;
Gramazio, A ;
Terzoli, E ;
Luzzani, M ;
DeMarinis, F ;
Caraceni, A ;
Labianca, R ;
Scarpi, E ;
Innocenti, MP ;
Vinci, M ;
Centrone, G ;
Marzola, M ;
Giaccon, G ;
Arnoldi, E ;
Gallucci, M ;
Frontini, L ;
Piva, L ;
Zaninetta, G ;
Petrella, V ;
Barni, S ;
Beretta, G ;
Calia, C ;
Moro, G ;
Cardamone, I ;
Groff, L ;
Amadori, D .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1997, 13 (01) :1-9
[9]  
Nakamura Itaru, 2009, Kansenshogaku Zasshi, V83, P363
[10]  
PANGALIS GA, 1993, SEMIN ONCOL, V20, P570